Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies Georgia RagiaVangelis G. Manolopoulos Review 21 July 2020 Pages: 1623 - 1630
Efficacy and safety of corticosteroid therapy in patients with cardiac arrest: a systematic review of randomised controlled trials Yajie LiJun ZhangFei He Review 21 July 2020 Pages: 1631 - 1638
Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials John P. ThomasYoon K. LokeLeo Alexandre Review Open access 28 July 2020 Pages: 1639 - 1651
Cinemeducation in clinical pharmacology: using cinema to help students learn about pharmacovigilance and adverse drug reactions Irene Cambra-BadiiMaría de Lluc FrancésJosep-E Baños Pharmacodynamics 04 September 2020 Pages: 1653 - 1658
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters Takayuki KatsubeYuji InoueToshihiro Wajima Pharmacokinetics and Disposition Open access 14 July 2020 Pages: 1659 - 1665
Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study Herman VeenhofHugo M. SchouwValentina Gracchi Pharmacokinetics and Disposition Open access 25 July 2020 Pages: 1667 - 1673
Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions Cécile SoutyTitouan LaunayThomas Hanslik Pharmacoepidemiology and Prescription 07 July 2020 Pages: 1675 - 1682
Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission Sarah SeiberthDominik BauerDorothea Strobach Pharmacoepidemiology and Prescription Open access 10 July 2020 Pages: 1683 - 1693
Pain severity and analgesics use in the community-dwelling older population: a drug utilization study from Germany Thi Ngoc Mai NguyenDana Clarissa LaetschBen Schöttker Pharmacoepidemiology and Prescription Open access 10 July 2020 Pages: 1695 - 1707
Safety of azithromycin in pediatrics: a systematic review and meta-analysis Linan ZengPeipei XuLingli Zhang Pharmacoepidemiology and Prescription Open access 17 July 2020 Pages: 1709 - 1721
Patients’ experiences on adverse drug reactions reporting: a qualitative study Rania Al DweikSanni YayaDafna Kohen Pharmacoepidemiology and Prescription 13 July 2020 Pages: 1723 - 1730
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis Caroline D. BindeIngunn F. TveteMarianne Klemp Pharmacoepidemiology and Prescription Open access 24 July 2020 Pages: 1731 - 1743
Blood pressure–lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials Jahad AlghamdiAbdulziz AlqadiSandosh Padmanabhan Pharmacoepidemiology and Prescription 21 July 2020 Pages: 1745 - 1754
Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China Peng-yuan ChenYuan-hui LiuPeng-cheng He Pharmacoepidemiology and Prescription 22 July 2020 Pages: 1755 - 1763
Drug exposure for PDA closure in France: a prospective, cohort-based, analysis Silvia IacobelliSimon LorrainFrancesco Bonsante Pharmacoepidemiology and Prescription 01 August 2020 Pages: 1765 - 1772
Durvalumab and multiple sclerosis: a causal link or simple unmasking? Francesca CaputoAlessia ManniDamiano Paolicelli Letter to the Editor 13 July 2020 Pages: 1773 - 1774
Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database Iole N. ChristodoulosTe-yuan ChyouPrasad S. Nishtala Letter to the Editor 28 July 2020 Pages: 1775 - 1776